SG11202010006UA - Hemp extract for treatment of pain in animals - Google Patents
Hemp extract for treatment of pain in animalsInfo
- Publication number
- SG11202010006UA SG11202010006UA SG11202010006UA SG11202010006UA SG11202010006UA SG 11202010006U A SG11202010006U A SG 11202010006UA SG 11202010006U A SG11202010006U A SG 11202010006UA SG 11202010006U A SG11202010006U A SG 11202010006UA SG 11202010006U A SG11202010006U A SG 11202010006UA
- Authority
- SG
- Singapore
- Prior art keywords
- pain
- animals
- treatment
- hemp extract
- hemp
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862655170P | 2018-04-09 | 2018-04-09 | |
PCT/US2019/026631 WO2019199861A2 (en) | 2018-04-09 | 2019-04-09 | Hemp extract for treatment of pain in animals |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202010006UA true SG11202010006UA (en) | 2020-11-27 |
Family
ID=68163314
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202010006UA SG11202010006UA (en) | 2018-04-09 | 2019-04-09 | Hemp extract for treatment of pain in animals |
Country Status (10)
Country | Link |
---|---|
US (2) | US20230110830A1 (en) |
EP (1) | EP3773528B1 (en) |
JP (1) | JP2021521277A (en) |
CN (1) | CN112969452A (en) |
AU (1) | AU2019251357B2 (en) |
BR (1) | BR112020020850A2 (en) |
CA (1) | CA3096842A1 (en) |
MX (1) | MX2020010603A (en) |
SG (1) | SG11202010006UA (en) |
WO (1) | WO2019199861A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20210275556A1 (en) * | 2018-07-02 | 2021-09-09 | Companion Sciences. LLC | Cannabidiol Combination Compositions |
US11484487B1 (en) * | 2018-07-23 | 2022-11-01 | Robell Research, Inc. | Gingivitis gum serum |
US20230090094A1 (en) * | 2019-07-02 | 2023-03-23 | Ellevet Sciences | Hemp extract for treatment of pain, cancer and epilepsy in animals |
CN111956664A (en) * | 2019-12-03 | 2020-11-20 | 云南汉盟制药有限公司 | Composition for pets and application thereof |
WO2021127749A1 (en) * | 2019-12-24 | 2021-07-01 | Cannadol Pharmaceuticals Ltd | Compositions comprising terpenes and their use in the treatment or alleviation of pain or anxiety |
WO2021226099A1 (en) * | 2020-05-04 | 2021-11-11 | Agronomed Management, Llc | Topical anti-inflammatory cannabinoid compositions |
IL299008A (en) * | 2020-06-12 | 2023-02-01 | Zelira Therapeutics Operations Pty Ltd | Composition and method for treating chronic pain |
US20220110888A1 (en) * | 2020-10-09 | 2022-04-14 | Charlotte's Web, Inc. | Composition for the treatment of psoriasis |
WO2023130161A1 (en) * | 2022-01-10 | 2023-07-13 | Dolce Cann Global Pty Ltd | Compositions and methods for treating non-neurological disorders with combination products comprising a cannabinoid mixture rich in cannabidiolic acid (cbda) along with an additional active agent |
WO2023130160A1 (en) * | 2022-01-10 | 2023-07-13 | Dolce Cann Global Pty Ltd | Compositions and methods for treating non-neurological disorders with combination products comprising a cannabinoid mixture rich in cannabidiolic acid (cbda). |
WO2023173060A1 (en) * | 2022-03-10 | 2023-09-14 | Portland Technology Holdings Llc | Compositions comprising hemp extract and related treatment methods |
KR102524364B1 (en) * | 2022-10-24 | 2023-04-24 | 전북대학교산학협력단 | Composition for preventing or treating periodontitis comprising cannabidiol and taurine |
Family Cites Families (90)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10051427C1 (en) | 2000-10-17 | 2002-06-13 | Adam Mueller | Process for the production of an extract containing tetrahydrocannabinol and cannabidiol from cannabis plant material and cannabis extracts |
EP1482917B1 (en) | 2002-02-01 | 2019-05-08 | GW Pharma Limited | Compositions comprising cannabidiolic acid for treatment of nausea, vomiting, emesis, motion sickness or like conditions |
GB0222077D0 (en) | 2002-09-23 | 2002-10-30 | Gw Pharma Ltd | Methods of preparing cannabinoids from plant material |
EP1559423A1 (en) * | 2004-02-02 | 2005-08-03 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Medicinal acidic cannabinoids |
CN1840051B (en) * | 2006-01-23 | 2013-08-28 | 北京因科瑞斯生物制品研究所 | Pain-stopping gel with musk and its preparation method |
US8481085B2 (en) | 2006-06-15 | 2013-07-09 | Gw Pharma Limited | Pharmaceutical compositions comprising cannabigerol |
GB2448535A (en) | 2007-04-19 | 2008-10-22 | Gw Pharma Ltd | New use for cannabinoid-containing plant extracts |
GB2450493A (en) | 2007-06-25 | 2008-12-31 | Gw Pharma Ltd | Cannabigerol for use in treatment of diseases benefiting from agonism of CB1 and CB2 cannabinoid receptors |
EP2044935B1 (en) | 2007-10-02 | 2011-01-05 | Vivacell Biotechnology Espana S.L. | A composition containing non-psychotropic cannabinoids for the treatment of inflammatory diseases |
GB2478595B (en) | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
NL2006621C2 (en) * | 2011-04-18 | 2012-10-22 | Fytagoras B V | New medical use for acidic cannabinoids. |
US8758826B2 (en) | 2011-07-05 | 2014-06-24 | Wet Inc. | Cannabinoid receptor binding agents, compositions, and methods |
GB2494461A (en) | 2011-09-12 | 2013-03-13 | Gw Pharma Ltd | Phytocannabinoids for use in the treatment of invasive cancers or metastases |
CA2850570A1 (en) | 2011-09-30 | 2013-04-04 | Glaxosmithkline Llc | Methods of treating cancer |
US9254272B2 (en) | 2011-11-30 | 2016-02-09 | Sutter West Bay Hospitals | Resorcinol derivatives |
WO2013147965A1 (en) * | 2012-03-28 | 2013-10-03 | Freeman Keith Gerald | Medical compositions, methods of making and using those compositions, and kits including those compositions |
US20140256692A1 (en) * | 2013-03-07 | 2014-09-11 | Nicholas Adam Brockman | Composition and Method for Alleviation of Pain and Inflammation |
GB2515312A (en) | 2013-06-19 | 2014-12-24 | Gw Pharma Ltd | The use of phytocannabinoids in the treatment of ovarian carcinoma |
WO2015025312A1 (en) * | 2013-08-21 | 2015-02-26 | Cannabics Pharmaceuticals Inc | Compositions for combined immediate and sustained release of cannabinoids, methods of manufacture and use thereof |
KR20160094950A (en) * | 2013-10-31 | 2016-08-10 | 풀 스펙트럼 래버러토리즈, 리미티드 | Terpene and cannabinoid formulations |
CA2931486A1 (en) | 2013-11-05 | 2015-05-14 | Ardent Llc | Sublingual cannabis dosage form and methods of making and using the same |
GB2527590A (en) | 2014-06-27 | 2015-12-30 | Otsuka Pharma Co Ltd | Active pharmaceutical ingredient (API) comprising cannabinoids for use in the treatment of cancer |
US20160000843A1 (en) | 2014-07-01 | 2016-01-07 | MJAR Holdings, LLC | High cannabidiol cannabis strains |
BR112017003966A2 (en) | 2014-08-25 | 2018-10-23 | Full Spectrum Laboratories Ltd | apparatus and methods for the simultaneous production of cannabinoid compounds |
WO2016064987A1 (en) * | 2014-10-21 | 2016-04-28 | United Cannabis Corp. | Cannabis extracts and methods of preparing and using same |
WO2016087649A2 (en) | 2014-12-04 | 2016-06-09 | Servicio Andaluz De Salud | Use of cannabinoids as ceramide-generating anticancer agents in tumors of the hematopoietic and lymphoid tissues |
JP2018505912A (en) | 2014-12-12 | 2018-03-01 | オーハイ エナジェティクス ピービーシー | Microencapsulated cannabinoid composition |
IL253664B (en) | 2015-01-31 | 2022-09-01 | Constance Therapeutics Inc | Methods for preparation of cannabis oil extracts and compositions |
AU2016215094B2 (en) * | 2015-02-05 | 2019-09-26 | Colorado Can Llc | Purified CBD and CBDA, and methods, compositions and products employing CBD or CBDA |
ES2860452T3 (en) | 2015-02-16 | 2021-10-05 | Apirx Pharmaceutical Usa Llc | Cosmetic and topical compositions comprising cannabigerol and cannabidiol |
US20170266153A1 (en) | 2015-02-27 | 2017-09-21 | Ebbu, LLC | Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes |
EP3265081A4 (en) * | 2015-03-02 | 2018-11-21 | Afgin Pharma, Llc | Topical regional neuro-affective therapy with cannabinoids |
EP3294289A4 (en) | 2015-05-13 | 2019-01-02 | One World Cannabis Ltd | Use of cannabis to treat fibromyalgia, methods and compositions thereof |
BR112017025388A2 (en) | 2015-05-28 | 2018-08-07 | Tweed Inc. | cannabis plants having modified expression of thca synthase |
BR112018001310A2 (en) * | 2015-07-22 | 2018-09-11 | Phytopharma Int Ltd | bee-ingestible compositions, methods of use thereof for the production of honey and honey produced by these |
US10064950B2 (en) | 2015-07-24 | 2018-09-04 | Shabana Naheed | Medication dispensing system |
GB2541191A (en) * | 2015-08-10 | 2017-02-15 | Gw Pharma Ltd | Use of cannabinoids in the treatment of epilepsy |
GB2542797A (en) | 2015-09-29 | 2017-04-05 | Gw Pharma Ltd | Use of cannabinoids in the treatment of inflammatory skin diseases |
EP3380096A4 (en) * | 2015-11-24 | 2019-10-23 | Constance Therapeutics, Inc. | Cannabis oil compositions and methods for preparation thereof |
US9956174B1 (en) | 2016-02-08 | 2018-05-01 | Jeff Nordahl | Packaged frozen cubes of cannabis juice purée with added decarboxylated cannabis material |
GB2549277B (en) | 2016-04-11 | 2021-02-17 | Gw Res Ltd | Cannabidiolic Acid for use in the Treatment of Autism Spectrum Disorder |
CA3020798A1 (en) | 2016-04-12 | 2017-10-19 | Scott SCHANEVILLE | Ingestible films having substances from hemp or cannabis |
WO2017177261A1 (en) | 2016-04-12 | 2017-10-19 | Habi Pharma Pty Ltd | Liposomal preparation and methods of treatment |
LT6486B (en) * | 2016-04-13 | 2018-01-10 | UAB "SatiMed" | The oleo gel composition and delivery system with active compounds from c. sativa and m. arvensis for reduction of inflamation and pain in deep tissues |
CN106074465A (en) * | 2016-06-14 | 2016-11-09 | 云南瑞酚生物科技有限公司 | Cannabinol compounds application in preparation treatment gouty arthritis medicine |
IL246790A0 (en) | 2016-07-14 | 2016-09-29 | Friedman Doron | Self-emulsifying compositions of cannabinoids |
PE20230607A1 (en) * | 2016-08-03 | 2023-04-13 | Zelda Therapeutics Operations Pty Ltd | CANNABIS COMPOSITION |
EP3503875A4 (en) | 2016-08-29 | 2020-06-24 | Canopy Growth Corporation | Water soluble compositions comprising purified cannabinoids |
CA3036636A1 (en) | 2016-09-14 | 2018-03-22 | Altria Client Services Llc | Smoking device |
IL248149B (en) * | 2016-09-29 | 2020-03-31 | Garti Nissim | Dilutable formulations of cannbinoids and processes for their preparation |
PE20200755A1 (en) * | 2017-01-14 | 2020-07-27 | Herbolea Biotech Srl | EXTRACTION BASED ON LIPID ASSISTED BY ENZYMES AND STABILIZATION OF PHYTO-CANNABINOIDS AND TERPENES, AND PRODUCTS OBTAINED FROM THE SAME |
WO2018175259A1 (en) * | 2017-03-18 | 2018-09-27 | Mcgarrah Steven M | Pet food including cannabidiolic acid |
WO2018175796A1 (en) | 2017-03-24 | 2018-09-27 | STAUFF, Deidra | Skin care compositions and methods |
WO2018187500A1 (en) | 2017-04-05 | 2018-10-11 | University Of Mississippi | Isolation of pure cannabinoids from cannabis |
CN110997006A (en) | 2017-05-08 | 2020-04-10 | 因美制药公司 | Ophthalmic drug delivery formulations |
WO2018217803A2 (en) | 2017-05-22 | 2018-11-29 | Growblox Life Sciences L.L.C. | Myrcene-containing complex mixtures targeting trpv1 |
WO2019003163A2 (en) | 2017-06-28 | 2019-01-03 | Buzzelet Development And Technologies Ltd. | Terpene-enriched cannabinoid product for women health |
JP7223744B2 (en) | 2017-07-26 | 2023-02-16 | ティージーエックス ソフト チュー エルエルシー | Starch-free soft chews for veterinary use |
US10597348B1 (en) | 2017-08-21 | 2020-03-24 | Jeff Nordahl | Infusing raw cannabinoids into food oil |
US11484510B2 (en) | 2017-08-28 | 2022-11-01 | Apirx Pharmaceutical Usa, Llc | Method to treat vitiligo |
US20190060250A1 (en) | 2017-08-28 | 2019-02-28 | Axim Biotechnologies, Inc. | Method to treat psoriasis |
US10272051B2 (en) | 2017-08-28 | 2019-04-30 | Axim Biotechnologies, Inc. | Method to treat atopic dermatitis |
EP3449992A1 (en) | 2017-09-04 | 2019-03-06 | Bionorica Ethics GmbH | Recovery of acidic cannabinoids from plant material |
AU2018330807A1 (en) | 2017-09-08 | 2020-03-05 | Scicann Therapeutics Inc. | Compositions comprising a cannabinoid and spilanthol |
US10654823B2 (en) | 2017-09-09 | 2020-05-19 | Scientific Holdings, Llc | Transparent glassy cannabinoid compositions |
US11473096B2 (en) | 2017-10-03 | 2022-10-18 | The Regents Of The University Of Colorado, A Body Corporate | Method for differentiating cannabis plant cultivars based on cannabinoid synthase paralogs |
WO2019071302A1 (en) | 2017-10-09 | 2019-04-18 | The University Of Sydney | Methods and compositions for treating or preventing seizures |
MX2020003661A (en) | 2017-11-30 | 2020-08-03 | Canopy Growth Corp | Liquid dosage forms, methods of making and use. |
WO2019113497A1 (en) | 2017-12-08 | 2019-06-13 | Biotech Institute LLC | High cannabigerol cannabis plants, methods of producing and methods of using them |
CA3090359A1 (en) | 2018-02-15 | 2019-08-22 | Syqe Medical Ltd. | Method and inhaler for providing two or more substances by inhalation |
WO2019159176A1 (en) | 2018-02-18 | 2019-08-22 | Scicann Therapeutics Inc. | Compositions and methods for treatment of neurodegenerative diseases |
US20190297821A1 (en) | 2018-03-28 | 2019-10-03 | Jack Hempicine Llc | Cross-hybridization of distinct homozygous cannabis plants to produce consistent early flowering seeds |
WO2019195752A1 (en) | 2018-04-05 | 2019-10-10 | Canopy Holdings, LLC | Hemp powder |
WO2019210401A1 (en) | 2018-05-01 | 2019-11-07 | Willinsky Michael | Novel anti-inflammatory, analgesic, anti-depressant cannabinoid and methods related to manufacture of same |
WO2019227167A1 (en) | 2018-06-01 | 2019-12-05 | The University Of Sydney | Compositions and treatments |
US10695316B2 (en) | 2018-07-03 | 2020-06-30 | Virgil Macaluso | Methods of heating cannabis plant material |
US20200288659A1 (en) | 2018-07-12 | 2020-09-17 | Jack Hempicine Llc | Production of cannabis plants and seeds using a targeted allele |
US20200015440A1 (en) | 2018-07-12 | 2020-01-16 | Jack Hempicine Llc | Production of cannabis plants and seeds using a targeted allele |
US20200015441A1 (en) | 2018-07-12 | 2020-01-16 | Jack Hempicine Llc | Production of cannabis plants and seeds using a targeted allele |
PT3823962T (en) | 2018-07-19 | 2023-04-26 | Al&Am Pharmachem Ltd | Process for purification of cannabinoic acids from plant material extract |
WO2020028875A1 (en) | 2018-08-02 | 2020-02-06 | DIVIOS, LLC (a California Limited Liability Company) | Sunscreen composition comprising cannabis extracts |
WO2020044123A1 (en) | 2018-08-27 | 2020-03-05 | Emerald Health Therapeutics Canada Inc. | Therapeutic combinations of boswellia extract and cannabinoids |
WO2020044118A1 (en) | 2018-08-27 | 2020-03-05 | Emerald Health Therapeutics Canada Inc. | Improved cannabinoid bioavailability |
MX2021002719A (en) | 2018-09-05 | 2021-09-23 | Nemus Bioscience Inc | Cannabinoids for the treatment of gram-positive infections including antibiotic-resistant bacterial strains. |
US10696646B2 (en) | 2018-10-18 | 2020-06-30 | Taba Ip, Llc | Purification of cannabinoids from crude cannabis oil |
WO2020084427A1 (en) | 2018-10-23 | 2020-04-30 | Radient Technologies Innovations Inc. | Temperature control for active compound extraction |
WO2020123383A1 (en) | 2018-12-10 | 2020-06-18 | Natural Extraction Systems, LLC | Compositions with novel cannabinoid and terpene profiles |
EP3893868A4 (en) | 2018-12-12 | 2022-08-10 | The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) | Compositions and methods for the treatment of cutaneous t cell lymphoma (ctcl) |
WO2020165902A1 (en) | 2019-02-15 | 2020-08-20 | Plantbiosis Ltd. | Method for synthesis of cannabis products |
NL2022616B1 (en) | 2019-02-21 | 2020-09-18 | Patrick Alexander Unger | Cannabigerol and pharmaceutical compositions comprising cannabigerol for use in the treatment of insomnia |
-
2019
- 2019-04-09 AU AU2019251357A patent/AU2019251357B2/en active Active
- 2019-04-09 EP EP19785569.5A patent/EP3773528B1/en active Active
- 2019-04-09 BR BR112020020850-7A patent/BR112020020850A2/en unknown
- 2019-04-09 CN CN201980037388.3A patent/CN112969452A/en active Pending
- 2019-04-09 CA CA3096842A patent/CA3096842A1/en active Pending
- 2019-04-09 MX MX2020010603A patent/MX2020010603A/en unknown
- 2019-04-09 US US17/045,945 patent/US20230110830A1/en active Pending
- 2019-04-09 JP JP2021505184A patent/JP2021521277A/en active Pending
- 2019-04-09 SG SG11202010006UA patent/SG11202010006UA/en unknown
- 2019-04-09 WO PCT/US2019/026631 patent/WO2019199861A2/en unknown
-
2022
- 2022-03-01 US US17/684,154 patent/US11712456B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2019199861A3 (en) | 2020-07-23 |
AU2019251357A1 (en) | 2020-12-03 |
BR112020020850A2 (en) | 2021-01-19 |
US20230110830A1 (en) | 2023-04-13 |
CN112969452A (en) | 2021-06-15 |
CA3096842A1 (en) | 2019-10-17 |
EP3773528A4 (en) | 2022-01-05 |
WO2019199861A2 (en) | 2019-10-17 |
JP2021521277A (en) | 2021-08-26 |
AU2019251357B2 (en) | 2023-10-05 |
EP3773528B1 (en) | 2024-01-10 |
MX2020010603A (en) | 2021-02-02 |
EP3773528A2 (en) | 2021-02-17 |
US20220211790A1 (en) | 2022-07-07 |
US11712456B2 (en) | 2023-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11202010006UA (en) | Hemp extract for treatment of pain in animals | |
IL268138A (en) | Combinations of cabozantinib and atezolizumab to treat cancer | |
IL259809A (en) | Apparatus and cosmetic method for cosmetic treatment of human mucosal tissue | |
IL279748A (en) | Composition and method for treating pain | |
EP3648841C0 (en) | Apparatus for internal organ, injury and pain treatment | |
EP3993780A4 (en) | Hemp extract for treatment of pain, cancer and epilepsy in animals | |
HK1249865B (en) | Treatment of pain | |
IL282473A (en) | Cosmetic method and therapeutic use for fat reduction | |
IL272036A (en) | Methods and compositions for treatment of pain using capsaicin | |
IL269743A (en) | Methods and compositions for treating retina-associated disease using ccr3-inhibitors | |
PL3326637T3 (en) | Use of mangosteen rind extract in preparation of medicine for treating skin diseases | |
SG11201705524SA (en) | Compositions and methods for the treatment of inflammation and pain | |
ZA202007320B (en) | Compounds for pain treatment, compositions comprising same, and methods of using same | |
EP3621619C0 (en) | Compounds and methods for treatment of visceral pain | |
IL280638A (en) | Fat tissue treatment | |
IL282685A (en) | Methods of treatment using anti-cd123 immunoconjugates | |
IL277962A (en) | Methods of treating neuropathic pain | |
IL268111A (en) | Methods of treating pain | |
IL247369A0 (en) | Compositions and methods for treatment of bone associated diseases | |
IL246608A0 (en) | Compositions and methods for treating heart disease | |
ZA201904327B (en) | Treatment of skin conditions | |
ZA201904326B (en) | Treatment of joint pain | |
GB201720401D0 (en) | Means and methods to treat torsin related neurologicl diseases | |
GB201720505D0 (en) | Methods for treatment of neuropathic pain | |
GB201811911D0 (en) | Treatment of disease |